Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate withdrawal after 6 versus 12 months of clinical remission in juvenile idiopathic arthritis
2005-001086-34Phase 3Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Jun 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methotrexate in juvenile idiopathic arthritis (JIA), sponsored by Istituto Giannina Gaslini. Started Jun 2005; status: active.
02
Drugs
methotrexate
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on 2005-001086-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001086-34.